Malone Daniel 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed May 1, 2019
Insider Transaction Report
Form 4
Malone Daniel
Vice President & Controller
Transactions
- Sale
Common Stock
2019-04-30$123.03/sh−4,458$548,477→ 29,020.393 total - Exercise/Conversion
Common Stock
2019-04-30$21.34/sh+4,458$95,134→ 33,478.393 total - Exercise/Conversion
Stock Options (Right to Buy)
2019-04-30−4,458→ 5,000 totalExercise: $21.34From: 2011-03-22Exp: 2020-03-22→ Common Stock (4,458 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $123.00 to $123.07, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.